LGND : Ligand Pharmaceuticals Incorporated stock forecast, predictions, and share price target for 2021, 2022 (1 year) to 2025, 2026 (5 year) to 2030, and 2031 (10 year)

The 4 Wall Street analysts offering Ligand Pharmaceuticals Incorporated stock forecast in the last 6 months have average price target of $225.75 with a high forecast of $310.0 and a low forecast of $195.0. The average Ligand Pharmaceuticals Incorporated stock forecast represents a 47.13% increase from the last price of $153.44. From AI system, total return is 1826.17% from 1567 forecasts. For Ligand Pharmaceuticals Incorporated stock forecast 2021, 8 predictions are offered for each month of 2021 with average Ligand Pharmaceuticals Incorporated stock forecast of $168.31, a high forecast of $176.01, and a low forecast of $156.69. The average Ligand Pharmaceuticals Incorporated stock forecast 2021 represents a 9.69% increase from the last price of $153.44. For Ligand Pharmaceuticals Incorporated stock forecast 2022, 12 predictions are offered for each month of 2022 with average Ligand Pharmaceuticals Incorporated stock forecast of $130.22, a high forecast of $152.16, and a low forecast of $112.18. The average Ligand Pharmaceuticals Incorporated stock forecast 2022 represents a -15.13% decrease from the last price of $153.44. For Ligand Pharmaceuticals Incorporated stock forecast 2025, 12 predictions are offered for each month of 2025 with average Ligand Pharmaceuticals Incorporated stock forecast of $39.39, a high forecast of $44.17, and a low forecast of $36.29. The average Ligand Pharmaceuticals Incorporated stock forecast 2025 represents a -74.33% decrease from the last price of $153.44. For Ligand Pharmaceuticals Incorporated stock forecast 2026 (5 year), 12 predictions are offered for each month of 2026 with average Ligand Pharmaceuticals Incorporated stock forecast of $40.83, a high forecast of $45.0, and a low forecast of $36.26. The average Ligand Pharmaceuticals Incorporated stock forecast 2026 represents a -73.39% decrease from the last price of $153.44. For Ligand Pharmaceuticals Incorporated stock forecast 2030, 12 predictions are offered for each month of 2030 with average Ligand Pharmaceuticals Incorporated stock forecast of $97.67, a high forecast of $104.35, and a low forecast of $91.69. The average Ligand Pharmaceuticals Incorporated stock forecast 2030 represents a -36.35% decrease from the last price of $153.44. For Ligand Pharmaceuticals Incorporated stock forecast 2031 (10 year), 4 predictions are offered for each month of 2031 with average Ligand Pharmaceuticals Incorporated stock forecast of $95.24, a high forecast of $99.25, and a low forecast of $92.68. The average Ligand Pharmaceuticals Incorporated stock forecast 2031 represents a -37.93% decrease from the last price of $153.44. Please, see more forecasts below.